Published in
Springer, Drug Safety, 7(44), p. 753-763, 2021
DOI: 10.1007/s40264-021-01072-0
Links
Tools
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
Journal article published in 2021 by
Efe Eworuke 
,
Laura Hou,
Rongmei Zhang,
Hui-Lee Wong,
Peter Waldron,
Abby Anderson,
Audrey Gassman,
David Moeny,
Ting-Ying Huang
,
Laura Hou,
Rongmei Zhang,
Hui-Lee Wong,
Peter Waldron,
Abby Anderson,
Audrey Gassman,
David Moeny,
Ting-Ying Huang
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 